UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 912

Sortiert nach

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Blood, 2021-01, Vol.137 (2), p.203-215

2021

Link zum Volltext

Verfügbarkeit prüfen

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Neuro-oncology (Charlottesville, Va.), 2021-07, Vol.23 (7), p.1056-1071

2021

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies

British journal of dermatology (1951), 2024-03, Vol.190 (4), p.559-564

2024

Link zum Volltext

Verfügbarkeit prüfen

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Journal of hematology and oncology, 2021-09, Vol.14 (1), p.1-140, Article 140

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BMC cancer, 2022-09, Vol.22 (1), p.971-9, Article 971

2022

Link zum Volltext

Verfügbarkeit prüfen

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Hematological oncology, 2019-12, Vol.37 (5), p.548-557

2019

Link zum Volltext

Verfügbarkeit prüfen

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

Blood, 2015-12, Vol.126 (25), p.2665-2675

2015

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

Bone marrow transplantation (Basingstoke), 2020-05, Vol.55 (5), p.884-890

2020

Link zum Volltext

Verfügbarkeit prüfen

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Health science reports, 2024-01, Vol.7 (1), p.e1749-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel

Experimental hematology & oncology, 2022-03, Vol.11 (1), p.17-17, Article 17

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation

Rheumatic & musculoskeletal diseases open, 2024-03, Vol.10 (1), p.e003980

2024

Link zum Volltext

Verfügbarkeit prüfen

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Haematologica (Roma), 2016-07, Vol.101 (7), p.803

2016

Link zum Volltext

Verfügbarkeit prüfen

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Journal of personalized medicine, 2023-07, Vol.13 (7), p.1182

2023

Link zum Volltext

Verfügbarkeit prüfen

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

Frontiers in immunology, 2019-10, Vol.10, p.2489-2489

2019

Link zum Volltext

Verfügbarkeit prüfen

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

British journal of haematology, 2020-09, Vol.190 (5), p.708-714

2020

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma

British journal of haematology, 2019-02, Vol.184 (3), p.348-363

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Therapeutic advances in hematology, 2023-01, Vol.14, p.20406207231173489-20406207231173489

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of secondary central nervous system lymphoma

British journal of haematology, 2023-01, Vol.200 (2), p.160-169

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Haematologica (Roma), 2019-02, Vol.104 (2), p.e68

2019

Link zum Volltext

Verfügbarkeit prüfen

Insights into the management of patients with primary central nervous system lymphoma

Clinical advances in hematology & oncology, 2022-04, Vol.20 (4), p.203

Fox, Christopher P

2022

Link zum Volltext

Verfügbarkeit prüfen

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

British journal of haematology, 2019-10, Vol.187 (2), p.185-194

2019

Link zum Volltext

Verfügbarkeit prüfen

The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

British journal of haematology, 2024-04, Vol.204 (4), p.1178-1192

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Clinical cancer research, 2020-07, Vol.26 (14), p.3589-3596

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 912

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(863)
Mit Volltextzugriff
(797)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(669)
Life Sciences & Biomedicine
(565)
Humans
(471)
Male
(286)
Female
(276)
Middle Aged
(174)
Aged
(162)
Adult
(125)
Biological And Medical Sciences
(121)
Medical Sciences
(107)
Cardiovascular System & Cardiology
(101)
Treatment Outcome
(89)
Cardiac & Cardiovascular Systems
(88)
Neurosciences & Neurology
(87)
General & Internal Medicine
(76)
Hematology
(76)
Animals
(74)
Risk Factors
(72)
Physical Sciences
(67)
Surgery
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(59)
Circulation
(27)
British Journal Of Haematology
(22)
Journal Of The American College Of Cardiology
(22)
The Journal Of Trauma And Acute Care Surgery
(21)
The American Heart Journal
(15)
Plos One
(14)
Nature
(12)
European Heart Journal
(11)
The Astrophysical Journal
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel

Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Management of secondary central nervous system lymphoma

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Insights into the management of patients with primary central nervous system lymphoma

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Aktive Filter

Suchergebnisse filtern